C12N 2740/15033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2740/15033 (Use of viral protein as therapeutic agent other than vaccine) appears on 12 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 22
- Assignees
- 21
- Inventors
- 44
- Latest grant
- 16 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 5 |
| 2017 | 2 | 0 |
| 2018 | 4 | 2 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for NK cell transduction16 Apr 2024US 11,957,715 B2Miltenyi Biotec GmbH
- Rewiring aberrant cancer signaling to a therapeutic effector response with a synthetic two-component system26 Mar 2024US 11,939,609 B2The Board of Trustees of the Leland Stanford Junior University
- DAGRS: directed antigonists to cancer cell growth signals12 Apr 2022US 11,299,516 B2
- Expansion of adult stem cells in vitro2 Oct 2018US 10,087,420 B2Taiga Biotechnologies, Inc.
- Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein10 Jul 2018US 10,017,784 B2ID Pharma Co., Ltd.
- Composition including virus like particles (vlps), a kit, and method for antitumoral therapy13 Aug 2026US 2026/0234573 A1Cnpem- Centro Nacional De Pesquisa Em Energia E Materiais
- Engineered protein g fusogens and related lipid particles and methods thereof13 Aug 2026US 2026/0234669 A1Sana Biotechnology, Inc.
- Engineered viral particles and uses of the same13 Feb 2025US 2025/0051797 A1Interius Biotherapeutics, Inc.
- Viral particle with surface stimulating molecules13 Feb 2025US 2025/0051801 A1Umoja Biopharma, Inc.
- Method for nk cell transduction17 Dec 2020US 2020/0390812 A1Miltenyi Biotec GmbH
Most cited
By later US patents
- Expansion of adult stem cells in vitro15US 9,365,825 B2Taiga Biotechnologies, Inc. · 2016
- Expansion of adult stem cells in vitro8US 10,087,420 B2Taiga Biotechnologies, Inc. · 2018
- Vaccine and therapeutic delivery system4US 9,925,257 B2Forsyth Dental Infirmary for Children · 2018
- Vaccine and therapeutic delivery system3US 9,376,686 B2Forsyth Dental Infirmary for Children · 2016
- Vaccine and therapeutic delivery system3US 9,884,108 B2Forsyth Dental Infirmary for Children · 2018